ANVISA is the Brazilian Health Surveillance Agency established in 1999 to coordinate the National Sanitary Surveillance System and other health programs. It is responsible for regulating drugs, medical devices, food, cosmetics and other products. ANVISA monitors prices, conducts inspections, and provides technical support. It aims to protect public health through sanitary control of production, marketing and borders. ANVISA is part of the decentralized National System of Sanitary Surveillance and works with various federal, state and municipal agencies.
The Therapeutic Goods Administration is the regulatory body for therapeutic goods in Australia.he TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard and that access to therapeutic advances is in a timely manner.
The document filing for a pharmaceutical product is done in the form of dossier. The slides explain the format and content to be included in all the formats of dossiers.
The Therapeutic Goods Administration is the regulatory body for therapeutic goods in Australia.he TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard and that access to therapeutic advances is in a timely manner.
The document filing for a pharmaceutical product is done in the form of dossier. The slides explain the format and content to be included in all the formats of dossiers.
Regulatory requirnment and approval procedure of drugs in japan pptsandeep bansal
this ppt is about all the rules and regulations of drugs in Japan.this ppt contains the PMDA structure, DMF data, IND and NDA procedure, cosmetic regulations, post marketing survelliance etc.
An Overview of CDSCO Registration. The CDSCO stands for Central Drugs Standard Control Organisation is the NRA or National Regulatory Authority under the Directorate General of Health Services, Government of India, and Ministry of Health and Family Welfare.
My presentation based on the CDSCO certification, as well as the complete description about the CDSCO and DCGI.
Regulatory requirnment and approval procedure of drugs in japan pptsandeep bansal
this ppt is about all the rules and regulations of drugs in Japan.this ppt contains the PMDA structure, DMF data, IND and NDA procedure, cosmetic regulations, post marketing survelliance etc.
An Overview of CDSCO Registration. The CDSCO stands for Central Drugs Standard Control Organisation is the NRA or National Regulatory Authority under the Directorate General of Health Services, Government of India, and Ministry of Health and Family Welfare.
My presentation based on the CDSCO certification, as well as the complete description about the CDSCO and DCGI.
Brazil International Ltd. is a boutique company that provides business
services for companies in the medical device field, seeking to
successfully penetrate and participate in the Brazilian market.
SISCOMEX - Sistema de Comércio ExteriorKelvin Felipe
O Siscomex visa a informatização dos procedimentos, controles e informações referentes à importação/exportação - que antes eram documentados em papel - através da criação de um fluxo de informações padronizadas, para que toda intervenção, pública ou privada, fosse registrada.
*O nome dos outros alunos que contribuíram para a elaboração deste conteúdo foi retirada, visando o direito de privacidade de cada um.
lecture presented at 3rd. March 2024 about the Iraqi pharmacovigilance system as part of the newly appointed pharmacist training course (2024),
Update was performed depending on the latest version of the (Iraqi Pharmacovigilance Guidelines for Healthcare Professionals) 2024
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptxDureshahwar khan
This presentation includes introduction to WHO International Drug Monitoring Program & its functions, Role of WHO in PV, Vigibase, regulatory terminology of ADR and evaluation of medication safety.
REGULATION AND STANDARDS OF MEDICAL DEVICES IN UGANDABrian Matovu
This slides briefly describe the role of different government bodies in regulation and setting of standards in Uganda. This work was presented on 17th November 2016 at the 5th East African Regional Scientific Conference and Exhibition in Nairobi Kenya at Meridian Hotel. ENJOY!!
IFPMA-TFDA Workshop on Couterfeit Medicines
‘Integrated Approach Against Fake Medicines’
Session 4: Collaboration within and between countries
On 6th February 2015
At Taipei International Convention Center
Taipei, Taiwan
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
1. ANVISAAgencia Nacional de Vigilancia
Sanitaria
By Prashant Patel
Department of pharmaceutical
technology
Indukaka Ipcowala college of pharmacy
2. Background
The National Health Surveillance Agency was
established in 1999 by president Fernando Henrique
Cardoso. Linked to the Ministry of Health, the agency
coordinates:
The National Sanitary Surveillance System
The National Program of Blood and Blood Products
The National Program of Prevention and Control of
Hospital Infections
3. Anvisa is responsible for
monitoring drug prices
prices of medical devices
control and inspection of smoking products
technical support in granting of patents by the National
Institute of Industrial Property.
protection of the health of the population by exercising
sanitary control over production
marketing of products and services subject to sanitary
surveillance, controlling ports, airports and borders
linked to the Brazilian Ministry of Foreign Affairs and foreign
institutions over matters concerning international aspects of
sanitary surveillance.
4. ANVISA is a part of NSSS
National System of Sanitary Surveillance (NSSS) is an
organization of Brazil whose responsibility is
to keep a watch over certain professional activities
to put a stop to charlatanism
to inspect ships, cemeteries and places where food was on
sale to the public.
5. The federal, state and municipal units of this sanitary
surveillance are:
National Agency for Sanitary Surveillance (ANVISA)
The National Council of State Health Secretaries
(CONASS)
The National Council of Municipal Health Secretaries
(CONASEMS)
The State, Federal District and Municipal Sanitary
Surveillance Centers (VISAS)
The Central Public Health Laboratories (LACENS)
The National Institute for Quality Control in Health
(INCQS)
The Oswaldo Cruz Foundation (FIOCRUZ)
6. Anvisa's Mission
"To protect and promote health, ensuring the
hygiene and safety of products and services and
taking part in developing access to it."
Values
Transparency
Knowledge (as a springboard for action)
Cooperation
Vision
To be an agent for transformation of the
decentralized sanitary surveillance system, within a
network, holding a distinct position, legitimized by
the population, as regulator and promotor of social
7. ANVISA Offices:
ANVISA has main two offices: Advisory council and
Office of Ombudsman.
Advisory Council
It monitors and follows up the development of
activities carried out by ANVISA.
Council comprise of Representatives from…
Public Administration Institutions
Organized Civil Society
Scientific Community
Function - to provide information upon request by any
citizen, patient, industrialist or health professional on any
topics.
8. Office of ombudsman
It is an independent body for direct communication of
Citizens or Institutes to attend the Complaints.
It is characterized by impartiality and transparency.
It has no direct or indirect linking with ANVISA. It is
regulated directly under the Brazilian ministry of
health. It Start action against complaints within 2
days, if appropriate.
9. Health Protection
Blood, Tissues, and Organs
Cosmetics
Drugs
Food
Health Related Services
Health Related Products
Laboratories
Medicine Bioavailability/Bioequivalence Centers
Pesticides and Toxicology
Pharmaceutical Ingredients
Ports, Airports, and Borders
Sanitizing Products
Tobacco Products
10. Blood, Tissues, and
Organs
To assure the quality of treatments based on the use of
blood, other tissues, cells, and human organs , Anvisa
formulates technical rules, inspects services, and
monitors the occurrence of adverse reactions caused by
technologies available in Brazil.
Products and processes that don’t follow quality
standards may be harmful and cause the transmission of
diseases such as AIDS, and Hepatitis B and C. For that
reason, the Brazilian Health Surveillance Agency works
to diminish or to avoid completely those risks.
11. Cosmetics
responsible for surveilling the marketing of hygiene
products, cosmetics, and perfumes. To guarantee the
quality of those products, Anvisa works at registration,
notification, and inspection.
The agency also creates norms and rules applicable to
the production processes, the techniques, the methods
and the use of those products by consumers.
12. Drugs
responsible for drug registration and licenses to
pharmaceutical laboratories and to other companies inside
the pharmaceutical production flow.
for establishing regulations applicable to clinical trials and
drug pricing, which is carried out by the Chamber of Drug
Market Regulation (CMED).
13. Together with states and municipalities, the agency
inspects
Factories
monitors the quality of drugs
exercises post-marketing surveillance
takes pharmacovigilance actions
regulates drug promotion and marketing.
analyzing patent requests related to pharmaceutical
processes and products, in partnership with the
National Industrial Property Institute (INPI).
Drugs
14. Food
coordinates, supervises, and controls activities
regarding registration, information, inspection, risk
control, and rulemaking to assure health surveillance
over food, beverages, water, ingredients, packages,
technologies, contamination limits, and veterinary
residues.
This work is done in cooperation with other
governmental bodies, such as the Ministry of Agriculture,
Livestock and Food Supply and the state and municipal
health offices, which take part of the National Health
Surveillance System.
15. Health Related Services
Health care quality is inextricably related to risk
monitoring. For that reason, health related services
surveillance is a necessary task, for it improves the
quality of health services
Anvisa coordinates nationwide health related services
surveillance actions, which are carried out by
states, municipalities, and the Federal District.
Besides, the agency formulates and enforces
rules, establishes controlling mechanisms, and
assesses risks and adverse events regarding health
provision in hospitals, clinics, and health posts.
16. Health Related Products
Health related products is a huge area comprised of
different levels of complexity, including infrared
lamps, magnetic resonance equipment, gauze
compress, hip prosthesis, culture medium, and HIV test
kit.
Those products are used in medical, dental, and
physiotherapeutic procedures, as well as in
diagnosis, treatment, rehabilitation and patient
monitoring.
17. Laboratories
responsible for coordinating health surveillance actions of
laboratories that take part of the official health quality control
laboratory net.
In 2004,they created the Public Health Laboratories National
System (SISLAB), to help improve the effectiveness of health
surveillance actions.
Laboratories Net performs analysis of products and services
such as food, drugs, cosmetics, sanitizing products,
immunobiologicals, blood products, toxic substances, biological
and non-biological contaminants, health materials and
equipment. Those analyses include areas of ports, airports,
and frontiers.
The base of this net is formed by the National Institute for
Quality Control in Health (INCQS), the State Health Public
18. Pesticides and Toxicology
Assessing, regulating, controlling and inspecting
products and services that pose health risks, including
pesticides, pesticides components, and other chemical
substances studied by toxicology.
The agency carries out toxicological analysis for new
pesticides registration and for the reevaluation of
molecules that have already been registered.
19. Pharmaceutical Ingredients
To assure the quality of drug production, Anvisa issues working
licenses and exerts health control over pharmaceutical
ingredients, by means of health inspection and rulemaking.
Anvisa is also responsible for investigating notifications on
quality control deviation. The pharmaceutical ingredients
represent the beginning of the pharmaceutical industry
production flow.
Anvisa is also responsible for analysing notifications on quality
control deviation.
20. Ports, Airports and Borders
Anvisa is committed to assuring the health control of
ports, airports, and borders. This is an important task, since
it protects the health of travelers, and guaranties the safety
of means of transport and services in those areas.
This work involves environments, processes, product
registration and approval, including ingredients and
technologies. Therefore, Anvisa enforces national and
international law such as the WHO International Health
Regulations (IHR), and other international acts signed by
Brazil.
21. Sanitizing Products
Sanitizing products are largely used for cleansing and
protecting environments such as houses, offices, shops,
and hospitals. To assure the efficacy of those products,
Anvisa makes their registration and notification,
observing all quality standards.
to enable quality improvement , the agency draws up
rules and standards, helps organizing information about
adverse events caused by sanitizing products,
undertakes constant risk assessment, monitors scientific
and technological development, and adopts corrective
procedures to eliminate, avoid or diminish the hazards
related to sanitizing products.
22. Tobacco Products
Includes rulemaking and law enforcement. To diminish
tobacco use, the agency has develop many actions:
obliged the use of health warnings on cigarette
packages and in cigarette advertising, prohibited
tobacco advertising outside tobacco shops as well as
food production that simulate tobacco products
24. Technovigilance
Technovigilance is a system created for monitoring after-
marketing adverse events and technical complaints
about health products.
The system aims at providing recommendations and
adopting measures that assure public promotion and
protection against hazards caused by products such as
health equipment, health materials, medical devices, in
vitro diagnostic products, and implants.
25. Advertising Monitoring
Anvisa promotes public education and monitors
advertising that may pose public health hazards. Both
kinds of work have been developed to reduce public
exposure to misleading and abusive advertising and to
help prevent problems such as self-medication,
intoxication, inadequate use of drugs and food.
This way, Anvisa aims at diminishing hazards to health,
supporting legislation improvement, and fostering
policies towards health education.
26. Hemovigilance
Hemovigilance is understood as a group of procedures
developed to monitor transfusion reactions. This work is done
to improve the quality of processes and products used in
hemotherapies and to provide patients safer treatments.
Health services that offer hemotherapies carry out
procedures to identify transfusion reactions or any adverse
events caused by blood and blood products therapies. Those
reactions should be notified, after which they become useful
information to identify risks and to avoid health problems
occurrence or reoccurrence.
Hemovigilance procedures are organized by the National
System of Hemovigilance (SNH), which is coordinated by
Anvisa.
27. Pharmacovigilance
Pharmacovigilance monitors drugs in the market. This kind of
post-marketing surveillance is put into practice by Anvisa, in
cooperation with states, municipalities and the Federal
District.
Although drugs are produced to prevent, alleviate or cure
diseases, they may cause undesirable and harmful effects.
This duality, sometimes tragic, is very significant to public
health and makes pharmacovigilance essential to health
surveillance in any country. Pharmacovigilance protects
people from harm by previously identifying risks and timely
acting.
28. ANVISA - Guidlines
REGISTRATION OF NEW DRUG
Registration procedure of new drug is divided in mainly 3 parts
as follows…
Pre-registration measures
Protocol for Clinical study
Registration
Documents to be submitted
Protocol for the new drug
Protocol for import of new drug
Post-registration
Alteration in Registration, Renewal of Registration
Thus, considered similar to IND, NDA and Supplementary
NDA as per US FDA.
29. TECHNICAL REGULATION OF
GENEERIC DRUGS
Registration procedure for Generic drug is similar to new
drug registration.
Pre registration measures
Registration
Post registration
Additional Requirements in registration includes…
Pharmaceutical Equivalence : Generic and Reference
If anyone of Generic or Reference is Coated tablet, prove
that coating does not present Gastro-protection
Bioequivalence study in Laboratories duly authorized by
ANVISA
Exemption of Bioequivalence study
Based on comparison of dissolution profile
For BCS Class I product – High solubility & permeability
30. Medicines NOT accepted as GENERIC
Parenteral that don’t contain API like WFI, glucose
solution, NaCl solution, electrolytes solution etc.
Biological products: Blood, Plasma products
Products obtained through Biotech except antibiotics
Herbal drug products
Vitamins &/or Mineral salts
Antiseptics for Hospital use
Endogenous Hormones of oral use
Products with Diagnostic purpose and Radiological
contrasts
Some of OTC products
31. HARMONIZATION OF ALREADY
REGISTERED DRUGS
ANVISA had introduced some modification in
Registration procedures and Documents after 1st
December 2004.
Drugs Registered before this date, has to submit
information or data or documents related to drug, for
harmonization with Newer Registered drug products.
32. GITE: List of Specified Therapeutic
Group & Indication
Drugs described in GITE can be sold OTC
Parenterals can not sold OTC (can not sell without
Prescription)
Drugs not listed in GITE can not sell without
PRESCRIPTION.
Any NEW DRUG, not to be sold under GITE
If New Drug has minimum 5 years experience in USA or
European market (with FDA or EMEA approval), and if it
comes under GITE list, applicator may request to
classify it as OTC product.
33. HOMEOPATHIC DRUGS
Registration of Homeopathic drugs is valid upto 5 years.
For Injectable Homeopathic medicines, applicator has to
submit Risk/Benefit compared with oral presentation of
same product
Combination of any synthetic/ semi-synthetic/ biological
product/ vitamins/ mineral salts/ herbal along with
Homeopathic is FORBIDDEN.
34. IN VITRO DIAGNOSTIC PRODUCT
ANVISA had classified in vitro diagnostic product into 4
classes as follows…
Group A - Materials, devices, accessories & inputs for
support of in vitro diagnostic products.
Group B - for diagnosis of non-transmissible diseases.
Group C - for diagnosis of infectious-contagious diseases,
except those classified in Group D.
Group D - for diagnosis of infectious-contagious diseases,
sexually transmissible diseases or diseases spread by
blood and blood products, as well as identification of blood
groups, transfusion or preparation of blood products.
35. Documents required for Registration…
Application form, Fee payment receipt
Copy of License or Permit for Manufacturing.
Label on the package of product, Instruction for Use
Technical Report
If imported, proof of Registration at competent health
agency of importing country
36. GMP
As per the latest updates of “GMP Guide for
Pharmaceutical Industry” approved by WHO’s World
Health Assembly – WHA.
GMP Certificate is Valid upto 1 year only
37. BA – BE GUIDELINES
Clinical Stage
Analytical Stage
Statistical Stage
BA – BE GOOD PRACTICE MANUAL
38. OTHER FUNCTIONS OF ANVISA:
REBLAS - Brazilian Network of Analytical Laboratories.
It is the laboratory network and every analysis and
clinical studies must be performing at any one of the
REBLAS center approved by ANVISA.
39. INDIAN PHARMA IN BRAZILIAN
MARKET
Prominent among them
are:
Zydus Cadila
Torrent Pharmaceuticals
Dr. Reddys Labs
Ranbaxy Pharmaceuticals
Intas Pharmaceuticals
Sun Pharmaceuticals
The major drugs exported
are:
Losartan Potassium
Zolpidem tartarate
Alprazolam
Enalapril Maleate
Nortryptiline
Carbamazepine
Clonazepam
Fluconazole
Fluoxetine, etc.
41. ANVISAAgencia Nacional de Vigilancia
Sanitaria
By Prashant Patel
(M.pharm sem-2)
Department of pharmaceutical
technology
Guided by:
Dr. D. R. C.
Department of Pharmaceutical
technology